Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MBRX

Moleculin Biotech, Inc.

CIK 0001659617 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.44
↑ 0.07 (2.95%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$13.02M
P/E Ratio
-0.33
EPS
-28.42
Dividend Yield
Not covered
52W Position
28%
Beta
1.04

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
0.86
P/S
Not covered
EV/Revenue
Not covered
ROE
-263.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 28%
$0.26$7.98

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$33.56M
Total Assets
$22.13M
Free Cash Flow
-$22.73M

Recent news